Daniel Lennartz, former Marketing Director, has accepted the position as the new Sales & Marketing Director in Europe for Mermaid Medical Group.
Copenhagen, Denmark, September 20th, 2021
Mermaid Medical Group announced today the appointment of former Marketing Director in Europe, Daniel Lennartz, as new Sales & Marketing Director in Europe. The appointment is another step towards strengthening the sales team and working towards a consolidated sales and marketing department. The marketing team will henceforward be led by Sebastian Jørgensen who until this point have held the position as Product Manager in Mermaid Medical Group.
“With the appointment of Daniel Lennartz to Sales & Marketing Director in Europe, we are adding an experienced salesperson and former Marketing Director to the sales team,” said Lars Vinther, CEO of Mermaid Medical Group. “Daniel will bring the best of both worlds to the team with his extensive experience working with sales as well as his experience leading a marketing team. I am confident that the appointment will benefit Mermaid Medical Group both in the short and long term.”
Daniel Lennartz holds a degree in Nursing and has acquired multiple diplomas and certificates within organizational leadership, business administration, and sales management. He has previously also held positions within Sales Management and Product Management.
“It is the beginning of a new adventure for me,” said Daniel Lennartz. “I can’t wait to begin the interesting and at times surely challenging role of working towards a more unified sales and marketing department.”
About Mermaid Medical Group
Mermaid Medical Group is a privately owned company established in 2007 devoted to developing, manufacturing, and distributing medical devices to hospitals and end users across Europe, the U.S., and Asia. Mermaid Medical primarily works within solutions to diseases in the vascular system as well as other devices used in interventional radiology and strive to be the preferred partner for manufacturers as well as hospitals and healthcare professionals in order to help patients across the world. For more information, visit www.mermaidmedical.com.
Mermaid Medical Group announces new exclusive distribution deal on the COBRA-OS® device for REBOA procedures from Front Line Medical Technologies Inc.
Mermaid Medical is proud to announce the appointment of Marcus Kildegaard Nielsen as the new global Sales Director, effective September 1st, 2024. Over the past six years, Marcus has made significant contributions in sales and marketing, bringing the right skills, ambitions, and mindset to ensure we keep driving the business forward.
Mermaid Medical proudly welcomes Daniel Nilsson Lennartz as the new Business Development Director, effective September 1st, 2024. As one of the co-founders, Daniel brings invaluable insights and expertise that will continue to drive the company’s growth and long-term success.